FDA Clears Anavex to Test Blarcamesine in Fragile X Syndrome, but It’s Not an Approval
The FDA cleared Anavex to test blarcamesine in Fragile X syndrome. It is a green light to run a trial, not an approval to sell a…
Fragile X syndrome
Local weather
Finding your area…National Weather Service
Trending
- College Football Week 6 Guide: Georgia-Alabama, Red River and Every Big Game to Watch
- 42% More Completed Foreclosures, but Housing Isn’t at a Breaking Point
- India Shows Caller Names From Nov. 1. What It Means for Your Calls
- Meta, Tesla and SpaceX Face Wall Street’s Big AI Test After a Brutal Week
- FDA Cleared an AI Breast Cancer Risk Score. Here’s What’s Unproven